
Part I. Financial Information Financial Statements For Q1 FY2025, the company reported increased revenues and net income, with total assets slightly up and liabilities significantly rising due to a declared special cash dividend Condensed Consolidated Balance Sheets As of July 31, 2024, total assets slightly increased to $84.3 million, while total liabilities significantly rose to $51.1 million, primarily due to a $9.6 million dividend payable Condensed Consolidated Balance Sheet Highlights (in thousands) | Balance Sheet Item | July 31, 2024 | April 30, 2024 | | :--- | :--- | :--- | | Cash and cash equivalents | $16,201 | $18,320 | | Total current assets | $59,225 | $58,121 | | Total assets | $84,264 | $83,253 | | Total current liabilities | $38,693 | $30,796 | | Dividend payable | $9,567 | $0 | | Total liabilities | $51,062 | $43,437 | | Total stockholders' equity | $33,202 | $39,816 | Condensed Consolidated Statements of Operations and Comprehensive Income For Q1 FY2025, revenues increased 21.5% to $15.1 million, with operating income rising to $2.4 million and net income reaching $2.4 million, or $0.25 per share Statement of Operations Highlights (in thousands, except per share data) | Metric | Three Months Ended July 31, 2024 | Three Months Ended July 31, 2023 | | :--- | :--- | :--- | | Revenues | $15,077 | $12,408 | | Gross Margin | $6,698 | $4,868 | | Operating Income | $2,365 | $2,060 | | Net Income | $2,430 | $2,042 | | Basic and Diluted EPS | $0.25 | $0.22 | Condensed Consolidated Statements of Cash Flows Net cash used in operating activities improved to $1.5 million for Q1 FY2025, with $0.3 million used in investing activities, ending the period with $17.4 million in cash Cash Flow Summary (in thousands) | Cash Flow Activity | Three Months Ended July 31, 2024 | Three Months Ended July 31, 2023 | | :--- | :--- | :--- | | Net cash used in operating activities | ($1,520) | ($2,801) | | Net cash used in investing activities | ($327) | ($187) | | Net cash used in financing activities | $0 | $0 | | Net decrease in cash | ($1,847) | ($2,988) | | Cash at end of period | $17,418 | $9,061 | Notes to Condensed Consolidated Financial Statements Notes detail a $9.6 million special cash dividend, segment performance with FEI-NY as the largest contributor, the write-off of a Russian investment, and ongoing remediation of a material weakness in internal controls - On July 22, 2024, the Board of Directors declared a special cash dividend of $1.00 per share, totaling approximately $9.6 million, paid on August 29, 202412 - The company operates under two reportable segments: FEI-NY (precision time and frequency control products) and FEI-Zyfer (GPS technology systems), with FEI-NY being the larger segment by revenue and assets1819 Revenues by Segment (in thousands) | Segment | Q1 FY2025 (ended Jul 31, 2024) | Q1 FY2024 (ended Jul 31, 2023) | | :--- | :--- | :--- | | FEI-NY | $10,975 | $9,490 | | FEI-Zyfer | $4,272 | $3,267 | Revenues by Product Line (in thousands) | Product Line | Q1 FY2025 (ended Jul 31, 2024) | Q1 FY2024 (ended Jul 31, 2023) | | :--- | :--- | :--- | | Satellite revenue | $8,263 | $4,858 | | Government non-space revenue | $6,270 | $6,878 | | Other commercial & industrial | $544 | $672 | - The investment in Morion, a Russian company, was written off in fiscal year 2022 due to the Russia-Ukraine conflict and sanctions, with a carrying value of $024 Management's Discussion and Analysis of Financial Condition and Results of Operations Management attributes the 21.5% revenue increase to U.S. Government sales, with gross margin improving to 44.4% and R&D expenses tripling, while maintaining a $20.5 million working capital and $70 million backlog Results of Operations Q1 FY2025 revenues rose 21.5% to $15.1 million, driven by satellite programs, with gross margin improving to 44.4% and R&D expenses significantly increasing due to product modernization Revenue Change by Segment (in thousands) | Segment | Q1 FY2025 Revenue | Q1 FY2024 Revenue | Change ($) | Change (%) | | :--- | :--- | :--- | :--- | :--- | | FEI-NY | $10,975 | $9,490 | $1,485 | 15.6% | | FEI-Zyfer | $4,272 | $3,267 | $1,005 | 30.8% | | Total | $15,077 | $12,408 | $2,669 | 21.5% | - The increase in revenue was primarily due to a $3.4 million increase in sales from space U.S. Government customers38 - Gross margin rate increased to 44.4% from 39.2% year-over-year, due to revenue from newer programs with higher margins and the completion of smaller, high-margin jobs40 - R&D expenses increased by $982,000 (194%) to $1.5 million, primarily due to a focus on advances and modernization of products42 Liquidity and Capital Resources Working capital decreased to $20.5 million as of July 31, 2024, with a current ratio of 1.5 to 1, and the funded backlog was approximately $70 million, which management deems adequate for future liquidity Liquidity Metrics | Metric | July 31, 2024 | April 30, 2024 | | :--- | :--- | :--- | | Working Capital | $20.5 million | $27.3 million | | Cash and cash equivalents | $16.2 million | $18.3 million | | Current Ratio | 1.5 to 1 | 1.9 to 1 | | Funded Backlog | ~$70 million | ~$78 million | - A special cash dividend of $1.00 per share, totaling approximately $9.6 million, was paid on August 29, 202450 - Approximately 65% of the $70 million backlog as of July 31, 2024, is expected to be realized in the next twelve months53 - The company believes its liquidity is adequate to meet its needs through at least September 16, 202554 Quantitative and Qualitative Disclosures About Market Risk This section is not applicable as the company qualifies as a smaller reporting company - Disclosure is not applicable to smaller reporting companies54 Controls and Procedures Management concluded that disclosure controls and procedures were ineffective as of July 31, 2024, due to a material weakness in loss provision accrual calculations, with remediation efforts underway - Management concluded that disclosure controls and procedures were not effective as of July 31, 202455 - A material weakness was identified in internal control over the calculation of loss provision accruals in contracts with customers, as controls did not sufficiently capture previously recognized contract losses59 - The company is remediating the weakness by updating its calculation methods and implementing enhanced review, reconciliation, and monitoring controls61 Part II. Other Information Risk Factors No material updates or changes to the company's risk factors have occurred since the last Form 10-K filing - There are no material updates or changes to the Company's risk factors since the filing of the Form 10-K64 Other Information No director or officer adopted or terminated a Rule 10b5-1 trading arrangement during the quarter - No director or officer adopted or terminated a Rule 10b5-1 trading arrangement during the quarter65 Exhibits This section lists filed exhibits, including CEO and CFO certifications and XBRL financial data - Filed exhibits include CEO and CFO certifications (31.1, 31.2, 32) and XBRL financial data (101, 104)66